Polycythemia Vera Market

The total prevalent population of Polycythemia Vera in the 7MM was 283,442 in 2017. The estimates show the highest prevalence of Polycythemia Vera in the United States with 157,290 cases in 2017. It is also observed that Males are more affected by Polycythemia Vera as compared to females in the 7MM market.

The therapeutic market of Polycythemia Vera in the seven major markets was assessed to be USD 951.68 Million in 2017 and is expected to grow during the study period (2017–2030).

For more detailed information on Polycythemia Vera market, visit:
https://www.delveinsight.com/report-store/polycythemia-vera-market